A Balanced Randomised Placebo Controlled Double-Blind Study to Investigate the Efficacy and Safety of AUT00063 versus Placebo in Subjective Tinnitus: Protocol for a Phase IIa Trial (2016)
Attributed to:
Biomedical Catalyst – Clinical proof of concept trial of a Kv3 modulator for the treatment of tinnitus
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: N/A
Issue: N/A